Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,406.03
(
0.07%
)
US TECH 100
28,383.60
(
0.33%
)
Dow Jones
49,562.89
(
-0.40%
)
Brent Oil
105.52
(
-0.23%
)
Bitcoin
79,680.10
(
-1.01%
)
News Focus
News Focus
Post# of 347009
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Protector

Send PM Follow Ignore
Followers 140
Posts 11663
Boards Moderated 0
Alias Born 03/15/2011

Protector

Re: corporalagarn post# 272483

Wednesday, 09/14/2016 9:53:34 AM

Wednesday, September 14, 2016 9:53:34 AM

Post# of 347009
corporal, that fact that you have mentioned that Bavi failed, which we both know isn't correct (Sunrise was stopped and as it didn't lead to approval one could call that a failure but we know, and will officially know with the up-coming presentation, that Bavi didn't fail.)

The control arm OVER PERFORMED in Sunrise where as for Opdivo alone it UNDER PERFORMED. And we are starting to see the trouble with Opdivo's further path to approval as we saw the past weeks.

Peregrine Pharmaceuticals the Microsoft of Biotechnology! All In My Opinion. I am not advising anything, nor accusing anyone.

Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote